Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This study looks to examine whether or not INTUNIV extended release can help children aged
6-12 years diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) in improving
Executive Function when added to their usual care stimulant therapy. Executive functions are
a set of mental processes that include emotional control, planning, organization, working
memory, inhibition of behaviors, and managing time and space. As children with ADHD usually
have difficulties with Executive Function, and Executive function difficulties lead to more
difficulties in school and behaviour, it is anticipated that adding INTUNIV extended release
to usual stimulant therapy will improve Executive Function scores as rated by parents and
teachers. Improvements in quality of life will also be measured.
Phase:
Phase 4
Details
Lead Sponsor:
JPM van Stralen Medicine Professional
Treatments:
Adderall Central Nervous System Stimulants Dextroamphetamine Guanfacine Methylphenidate